Virginia Attorney General Jason Miyares announced Tuesday that his office is looking into whether several insulin manufacturers and pharmacy benefit managers artificially inflated costs of diabetic medications. Pharmacy benefits managers act as intermediaries between health plans, drug manufacturers and pharmacies. In the cases that Miyares’ office is investigating, the question is if certain PBMs and drug producers raised costs in violation of the Virginia Consumer Protection Act. My Office is investigating the companies behind the soaring cost of insulin to protect Virginia families,” Miyares said in a release announcing the investigation on Tuesday. Spanberger reiterated her support in an August interview, after previously disclosing it at a campaign event this summer.